- Home
- NAMS vs CRGY Comparison
NAMS vs CRGY Comparison
Compare NAMS & CRGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMS | CRGY |
|---|---|---|
| Founded | 2019 | 1986 |
| Country | Netherlands | United States |
| Employees | 100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.3B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NAMS | CRGY |
|---|---|---|
| Price | $34.89 | $12.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $46.75 | $14.36 |
| AVG Volume (30 Days) | 794.4K | ★ 8.3M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $3,579,782,000.00 |
| Revenue This Year | $17.96 | $29.90 |
| Revenue Next Year | $540.65 | N/A |
| P/E Ratio | ★ N/A | $99.08 |
| Revenue Growth | N/A | ★ 22.14 |
| 52 Week Low | $14.92 | $7.68 |
| 52 Week High | $42.00 | $14.02 |
Technical Indicators
Market Signals| Indicator | NAMS | CRGY |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 52.67 |
| Support Level | $34.05 | $8.29 |
| Resistance Level | $37.43 | $14.02 |
| Average True Range (ATR) | 1.69 | 0.57 |
| MACD | 0.59 | -0.15 |
| Stochastic Oscillator | 90.80 | 41.80 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The Company's investing and operating activities are focused in Texas and the Rocky Mountain region.